Advisory Group: ‘Near Perfect Storm’ Coming On Gene Patents In The US
A report by a United States health department advisory group issued last week presents recommendations aimed at preventing patents on genes and licensing practices in the US from negatively impacting patient access to genetic tests that would allow them to establish their genetic dispositions to declare potential illnesses.

The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The February edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.